BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616
18 results:

  • 1. cervical lymphoepithelioma-like carcinoma with deficient mismatch repair and loss of smarca4/brg1: a case report and five related cases.
    Miyama Y; Kato T; Sato M; Yabuno A; Hasegawa K; Yasuda M
    Diagn Pathol; 2024 Jan; 19(1):6. PubMed ID: 38178127
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours].
    Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Le Frere Belda MA; Averous G; Leroux A; Bataillon G; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
    Bull Cancer; 2024 Jan; 111(1):97-116. PubMed ID: 37806863
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. smarca4-Deficient Carcinoma of Uterine Cervix Resembling SCCOHT-Case Report.
    Sirák I; Laco J; Vošmiková H; Mell LK; Herrera FG; Šenkeříková M; Vošmik M
    Pathol Oncol Res; 2021; 27():1610003. PubMed ID: 34970085
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Primary Synovial Sarcoma of the Uterine Cervix: First Case Report.
    Vaziri Fard E; Zhang S; El Achi HS; Covinsky M
    Int J Gynecol Pathol; 2021 Mar; 40(2):196-203. PubMed ID: 33075021
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
    Chu YH; Wirth LJ; Farahani AA; Nosé V; Faquin WC; Dias-Santagata D; Sadow PM
    Mod Pathol; 2020 Dec; 33(12):2458-2472. PubMed ID: 32737449
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Imaging features of smarca4-deficient thoracic sarcomas: a multi-centric study of 21 patients.
    Crombé A; Alberti N; Villard N; Pilleul F; Buy X; Le Loarer F; Kind M
    Eur Radiol; 2019 Sep; 29(9):4730-4741. PubMed ID: 30762113
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. smarca4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.
    Kolin DL; Dong F; Baltay M; Lindeman N; MacConaill L; Nucci MR; Crum CP; Howitt BE
    Mod Pathol; 2018 Sep; 31(9):1442-1456. PubMed ID: 29700418
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of Li-Fraumeni Syndrome With Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Concurrent Pleomorphic Liposarcoma of the Cervix.
    Tandon B; Hagemann IS; Maluf HM; Pfeifer JD; Al-Kateb H
    Int J Gynecol Pathol; 2017 Nov; 36(6):593-599. PubMed ID: 28177947
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Recently characterized molecular events in uncommon gynaecological neoplasms and their clinical importance.
    Witkowski L; McCluggage WG; Foulkes WD
    Histopathology; 2016 Dec; 69(6):903-913. PubMed ID: 27504996
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract.
    Mirkovic J; Sholl LM; Garcia E; Lindeman N; MacConaill L; Hirsch M; Dal Cin P; Gorman M; Barletta JA; Nucci MR; McCluggage WG; Howitt BE
    Mod Pathol; 2015 Nov; 28(11):1504-14. PubMed ID: 26336887
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. SWI/SNF complexes are required for full activation of the DNA-damage response.
    Smith-Roe SL; Nakamura J; Holley D; Chastain PD; Rosson GB; Simpson DA; Ridpath JR; Kaufman DG; Kaufmann WK; Bultman SJ
    Oncotarget; 2015 Jan; 6(2):732-45. PubMed ID: 25544751
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. brg1 regulates the transcription of human papillomavirus type 18 E6 and E7 genes.
    He H; Luo Y
    Cell Cycle; 2012 Feb; 11(3):617-27. PubMed ID: 22262178
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical significance of osteopontin expression in cervical cancer.
    Cho H; Hong SW; Oh YJ; Kim MA; Kang ES; Lee JM; Kim SW; Kim SH; Kim JH; Kim YT; Lee K
    J Cancer Res Clin Oncol; 2008 Aug; 134(8):909-17. PubMed ID: 18210151
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes.
    Narayan G; Bourdon V; Chaganti S; Arias-Pulido H; Nandula SV; Rao PH; Gissmann L; Dürst M; Schneider A; Pothuri B; Mansukhani M; Basso K; Chaganti RS; Murty VV
    Genes Chromosomes Cancer; 2007 Apr; 46(4):373-84. PubMed ID: 17243165
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Downregulation of BRG-1 repressed expression of CD44s in cervical neuroendocrine carcinoma and adenocarcinoma.
    Kuo KT; Liang CW; Hsiao CH; Lin CH; Chen CA; Sheu BC; Lin MC
    Mod Pathol; 2006 Dec; 19(12):1570-7. PubMed ID: 16998464
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. RB and cell cycle progression.
    Giacinti C; Giordano A
    Oncogene; 2006 Aug; 25(38):5220-7. PubMed ID: 16936740
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Maintenance of integrated proviral gene expression requires Brm, a catalytic subunit of SWI/SNF complex.
    Mizutani T; Ito T; Nishina M; Yamamichi N; Watanabe A; Iba H
    J Biol Chem; 2002 May; 277(18):15859-64. PubMed ID: 11850427
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Human SWI-SNF component brg1 represses transcription of the c-fos gene.
    Murphy DJ; Hardy S; Engel DA
    Mol Cell Biol; 1999 Apr; 19(4):2724-33. PubMed ID: 10082538
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.